Teva Pharmaceutical Industries Limited

WHO'M
ai
Digital Profiler. Einfach den AI-Button klicken
CUSIP

881624209
SEDOL

2883878
CIK

0000818686

www.tevapharm.com
LEI: 549300BAFGM4RC74ZJ94
FIGI: BBG000C0CD58
TEVA

Teva Pharmaceutical Industries Limited
GICS: - · Sektor: Healthcare · Sub-Sektor: Drug Manufacturers - Specialty & Generic
AI
PROFILER
NAME
Teva Pharmaceutical Industries Limited
ISIN
US8816242098
TICKER
TEVA
MIC
XNYS
REUTERS
TEVA.N
BLOOMBERG
TEVA US
FÜR INVESTOREN
FÜR TRADER

Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von PR-Newswire bereitgestellt.

Fr., 14.03.2025       Teva Pharmaceutical
US8816242098

HONG KONG, March 14, 2025 /PRNewswire/ -- Teva Hong Kong ("Teva"), has announced a strategic partnership with Kerry Pharma, the subsidiary of Kerry Logistics Network Ltd ("KLN"). Leveraging Kerry Pharma's extensive logistics (fourth-party logistics, 4PL) distribution capabilities, this collaboration aims to enhance Teva's pharmaceutical distribution system in Hong Kong, Macau, and the Greater Bay Area, ensuring a stable supply of high-quality medical products. This initiative not only strengthens Teva's presence in Hong Kong, Macau, and the Greater Bay Area, enhancing product distribution system resilience and driving quality and efficiency improvements in the regional pharmaceutical industry, but also marks a crucial step in building an efficient, transparent, and sustainable pharmaceutical supply model that prioritizes patient care.

We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Informationen zu Product Placements

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S